Abstract
This research service covers the U.S. stem cell market: current developments.
Included are a disease overviews for main indications, estimated patient
penetration for main indications, technology trends,and total market
potential. The market is segmented by cell type: adult stem cell and embryonic
stem cell. Major market challenges and drivers are identified and discussed.
|